Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Prostatic Neoplasms 2Neoplasm, Residual 2Lymphoma 2Esophageal Stenosis 2Prostate Cancer Metastatic 1Polycystic Ovary Syndrome 1Myasthenia Gravis 1Metastatic Castration-Resistant Prostate Cancer 1Mediastinal Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1Infertility 1Hodgkin Disease 1Hemangioma 1Esophageal Neoplasms 1Burkitt Lymphoma 1Barrett Esophagus 1Adrenal Insufficiency 1

Interventions

Prednisone 2enzalutamide 1cabazitaxel 1Prednisolone 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Prostate Cancer Metastatic × Prednisolone × Clear all
NCT02074137 2016-06-02

Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer

Sanofi

Phase 4 Completed
10 enrolled
Genitourinary

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡